Planning

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

National Generic Pharmaceuticals - Project Revive

NHS England

This public procurement record has 2 releases in its history.

PlanningUpdate

20 Aug 2026 at 11:54

UK2 - Preliminary Market Engagement Notice
Planning

12 Aug 2026 at 08:24

UK2 - Preliminary Market Engagement Notice
Summary of the contracting process

NHS England intends to procure national generic pharmaceutical products through Project Revive, supporting resilience and patient access in the NHS secondary-care supply chain. The programme is being delivered with the Medicines and Healthcare products Regulatory Agency and Medicines UK. It aims to reactivate dormant or unmarketed MHRA-approved marketing authorisations for critical medicines and to develop new supply routes in strategically important areas. The procurement is for goods rather than services or works and is expected to cover supply across NHS England. Specific products will be set out in the future invitation to tender. This is relevant to pharmaceutical manufacturers, marketing-authorisation holders and other suppliers able to provide generic medicines for secondary-care use, including businesses developing new routes to market.

This procurement is at the planning stage: NHS England has announced its intention to tender, but has not yet issued an invitation to tender. The expected procedure is a framework agreement, with the tender issue expected on 1 October 2026. Market engagement is scheduled to run until 25 September 2026. The planned contract is expected to start on 1 April 2027 and run for 22 months to 31 January 2029, with an extension option allowing a maximum total term of 48 months, to 31 March 2031. The recorded estimated value is £1 excluding VAT and £1.20 including VAT. The procurement is above the applicable threshold and is planned as one lot, identified as suitable for small and medium-sized enterprises.

The procurement is intended for suppliers with the regulatory, manufacturing and distribution capability to bring generic pharmaceuticals into secondary-care supply chains. Suppliers holding dormant or unmarketed MHRA-approved marketing authorisations may be well placed, as may businesses able to reactivate licences or establish new compliant supply routes for strategically important critical products. Existing pharmaceutical suppliers and potential new entrants are both being targeted through the engagement process. The framework structure may suit businesses seeking a route to supply multiple NHS requirements over time, while the stated suitability for small and medium-sized enterprises indicates that participation is not limited to large national manufacturers. Companies should prepare evidence of product approvals, reliable supply capacity and medicines supply-chain resilience.

How relevant is this notice?

Notice Information

Notice Title

National Generic Pharmaceuticals - Project Revive

Notice Description

National Generic Pharmaceuticals - Project Revive DCE/DSW regions - 01/04/27 to 31/01/29 (22 months) DLS/DNE regions - 01/04/27 to 31/01/29 (22 months) DLN/DNW regions - 01/04/27 to 31/01/29 (22 months)

Planning Information

NHS England is advising suppliers of an upcoming tender for the NHS National Generic Framework – Project Revive to commence on 1st April 2027 for 22 months with the option to extend to a maximum total contract length of 48 months. Project Revive was announced as an action to be delivered in the Government’s Supply Resilience Strategy, published August 2025. Project Revive is a collaboration between NHS England, MHRA and Medicines UK. This is a project aimed at reactivating dormant licences and seeking new supply routes in strategically important areas to support supply from late this year / early 2027. Project Revive will focus on secondary care supply chain resilience only. The programme aims to strengthen supply chain resilience and patient access by reactivating dormant/not marketed MHRA approved Marketing Authorisations for critical products. The purpose of this notice is to inform existing and potential new suppliers of this procurement. Useful information for suppliers can be found here: https://www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ and the current generics workplan here: https://www.england.nhs.uk/publication/generics-framework-workplan-by-product-report/ . Specific information regarding the products included in this procurement will be provided in the ITO, which will be issued shortly.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06e1ed
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/079388-2026
Current Stage
Planning
All Stages
Planning

Procurement Classification

Notice Type
UK2 - Preliminary Market Engagement Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£1
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
20 Aug 20266 days ago
Submission Deadline
Not specified
Future Notice Date
1 Oct 20262 months to go
Award Date
Not specified
Contract Period
1 Apr 2027 - 31 Jan 2029 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Planning
Lots Status
Planning
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
Not specified
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...